Heart Rhythm

View the latest content related to this topic

News Conference News AHA 2025

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.

Caitlin E. Cox

November 18, 2025

Slides

See all

Presentation ESC 2025

ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation

Presenter: Jonas Oldgren

August 30, 2025

Presentation ESC 2025

POTCAST: A Randomized Controlled Trial Showing Arrhythmia Prevention Using Targeted Plasma Potassium Levels in ICD Patients

Presenter: Henning Bundgaard

August 29, 2025

Presentation ESC 2025

AMALFI: Active Monitoring for Atrial Fibrillation: A randomized controlled trial of remote screening for asymptomatic atrial fibrillation

Presenter: Rohan Wijesurendra

August 29, 2025

Presentation Controversies and Advances 2025

Debate: In 2025, Who Should Get Catheter Ablation for Atrial Fibrillation?

Presenter: Edward P. Gerstenfeld

January 31, 2025

Presentation Controversies and Advances 2025

One Size Does Not Fit All: Only Selected Patients Should Go For AF Ablation

Presenter: Sanjay Dixit

January 31, 2025

News

See all

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

By Caitlin E. Cox

December 01, 2025

News Daily News

HRS/ACC Give Advice on Ablations in Ambulatory Surgical Centers

By Todd Neale

November 25, 2025

News Conference News AHA 2025

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

By Caitlin E. Cox

November 18, 2025

News Conference News AHA 2025

Sham-Controlled Trial, and More, Bolster Pulsed-Field Ablation for AF

By Todd Neale

November 17, 2025

News Conference News AHA 2025

DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation

By Todd Neale

November 12, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Heart Rhythm

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

Slides

ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation

POTCAST: A Randomized Controlled Trial Showing Arrhythmia Prevention Using Targeted Plasma Potassium Levels in ICD Patients

AMALFI: Active Monitoring for Atrial Fibrillation: A randomized controlled trial of remote screening for asymptomatic atrial fibrillation

Debate: In 2025, Who Should Get Catheter Ablation for Atrial Fibrillation?

One Size Does Not Fit All: Only Selected Patients Should Go For AF Ablation

News

TCTMD’s Top 10 Most Popular Stories for November 2025

HRS/ACC Give Advice on Ablations in Ambulatory Surgical Centers

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

Sham-Controlled Trial, and More, Bolster Pulsed-Field Ablation for AF

DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Heart Rhythm

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content